HiberCell
Developing Novel Therapeutics to Prevent Cancer Relapse and Metastasis. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD417—625m (Dealroom.co estimates May 2021.)
New York City New York (HQ)
Authorizing premium user...